test

Analyst Coverage

Corporate Presentations

AI Collaborations

Clinical Trials

Compassionate Use

Expanded Access - GBM

Expanded Access - TNBC

Board of Directors

Lantern Careers

Contact Investors

Heading

Program

Indication

Discovery

Optimization

Preclinical

Pre IND

Phase I

Phase II

LP-300

NSCLC (Non-Small Cell Lung Cancer)

LP-100

Metastatic Castration Resistant Prostate Cancer

LP-184

CNS Cancers

Glioblastoma(GBM)

ATRT

Brain Mets

Pediatric Brain Cancers

Solid Tumors

Pancreatic Cancer

Bladder Cancer

TNBC

LP-284

Non-Hodgkin's Lymphomas

Mantle Cell

Double Hit

ADC

Select Solid Tumors